Advisory Committees PDF Print E-mail
Scientific Advisory Committee

Chief Science Advisor
Garry Neil, M.D.
(Committee Chairman)
Corporate Vice President
Corporate Office of Science & Technology Johnson & Johnson
New Brunswick, New Jersey

Clinical Pharmacology Advisory Committee
Darrell R. Abernethy, M.D., Ph.D.
Associate Director For Drug Safety
Office of Clinical Pharmacology Food and Drug Administration
Silver Spring, Maryland

Pharmaceutics Advisory Committee
William J. Curatolo, Ph.D.
Senior Research Fellow
Pfizer Global Research & Development
Pfizer Inc.
Groton, Connecticut

Informatics Advisory Committee
Peter A. Schad, Ph.D.
Scientist & Director RTI International
Research Triangle Park, North Carolina
George C. Fuller, Ph.D.
Basic Pharmacology Advisory Committee
George C. Fuller, Ph.D.
Professor Emeritus and Former Dean
Pharmaceutical Sciences
Wayne State University
Detroit, Michigan
Jean Paul Gagnon, Ph.D.
Health Outcomes Advisory Committee
Jean Paul Gagnon, Ph.D.
Senior Director, Public Policy
sanofi-aventis
Bridgewater, New Jersey



Informatics Advisory Committee
Peter A. Schad, Ph.D.
(Chairman)
Scientist & Director RTI International Research Triangle Park, North Carolina
Clark Golestani
Vice President MRL IT
Merck & Co., Inc.
Whitehouse Station, New Jersey
George R. Lenz, Ph.D. MBA
GRLEN R&D Associates
Andover, Massachusetts

Michael N. Liebman, Ph.D.
President/Managing Director
Strategic Medicine, Inc.
Kennett Square, Pennsylvania

Robert N. McBurney, Ph.D.
Former Executive Vice President
Theragenetics, Ltd.
Cambridge, Massachusetts
David B. Searls, Ph.D.
Former Senior Vice President
Worldwide Bioinformatics
GlaxoSmithKline
King of Prussia, Pennsylvania


Basic Pharmacology Advisory Committee
George C. Fuller, Ph.D.
(Chairman)
Professor Emeritus and Former Dean
Pharmaceutical Sciences
Wayne State University
Detroit, Michigan
Daniel Acosta, Jr., Ph.D.
Dean
College of Pharmacy
University of Cincinnati - Medical Ctr.
Cincinnati, Ohio
James W. Aiken, Ph.D.
President and CEO
Keystone Symposia on Molecular & Cellular Biology
Silverthorne, Colorado
Terry L. Bowlin, Ph.D.
Chief Scientific Officer
Microbiotix, Inc.
Worcester, Massachusetts 01605
Sue Piper Duckles, Ph.D.
Professor and Associate Dean
Department of Pharmacology
College of Medicine
University of California
Irvine, California
Salvatore J. Enna, Ph.D.
Professor
Department of Pharmacology
University of Kansas Medical Center
Kansas City, Kansas
Paul S. Guth, Ph.D.
Professor of Pharmacology
School of Medicine
Tulane University
New Orleans, Louisiana
Robert A. Kramer, Ph.D.
Vice President, Oncology and Immunology Drug Discovery
Bristol-Myers Squibb Company
Princeton, New Jersey
George R. Lenz, Ph.D. MBA
GRLEN R&D Associates
Andover, Massachusetts
Harry LeVine, III, Ph.D.
Center on Aging, Dept. of Molecular & Cellular Biochemistry
University of Kentucky
Lexington, Kentucky
Sidney Pestka, M.D.
Chairman and Professor
Department of Molecular Genetics and Microbiology and Immunology
University of Medicine & Dentistry of New Jersey
Robert Wood Johnson Medical School
Piscataway, New Jersey
Darryle D. Schoepp, Ph.D.
Senior Vice President & Franchise Head, Neuroscience
Merck Research Laboratories
North Wales, Pennsylvania
Patricia Seymour, M.D.
Associate Research Fellow
Pfizer Inc
Groton, Connecticut
James J. Starling, Ph.D.
Chief Scientific Officer
Cancer Cell Growth and Survival
Drug Hunting Team
Lilly Research Laboratories
Indianapolis, Indiana
Stephanie W. Watts, Ph.D.
Professor, Pharmacology & Toxicology
Assistant Dean, The Graduate School
Michigan State University
East Lansing, Michigan
Megan Yao, Ph.D.
Unit Head Oncology Pharmacology
Novartis Institute for Biomedical Research
Cambridge, Massachusetts 

Clinical Pharmacology Advisory Committee

Darrell R. Abernethy, M.D., Ph.D.
(Chairman)
Associate Director for Drug Safety Office of Clinical Pharmacology
Food and Drug Administration
Silver Spring, Maryland
Arthur J. Atkinson, Jr., M.D.
Adjunct Professor
Department of Molecular Pharmacology and Biochemistry
Feinberg School of Medicine
Northwestern University
Richland, Michigan
Terrence F. Blaschke, M.D.
Professor of Medicine and Molecular Pharmacology
Division of Clinical Pharmacology
Stanford University, School of Medicine
Stanford, California
Perry V. Halushka, M.D., Ph.D
Professor of Pharmacology and Medicine
Dean, College of Graduate Studies
Medical University of South Carolina
Charleston, South Carolina
  

Pharmaceutics Advisory Committee

William J. Curatolo, Ph.D.
(Chairman)
Senior Research Fellow
Pfizer Global Research & Development
Pfizer Inc
Groton, Connecticut
Bradley D. Anderson, Ph.D.
H.B. Kostenbauder Professor
University of Kentucky
Lexington, Kentucky
Michael J. Hageman, Ph.D.
Group Director
Bristol-Myers Squibb Company
Princeton, New Jersey
Charles Russel Middaugh, Ph.D.
Distinguished Professor of Pharmaceutical Chemistry
University of Kansas
Lawrence, Kansas
Patrick J. Sinko, Ph.D.
Associate Vice President for Research
Rutgers, The State University of New Jersey
Parke-Davis Professor of Pharmaceutics & Drug Delivery
Piscataway, New Jersey

Health Outcomes Advisory Committee

Jean Paul Gagnon, Ph.D.
(Chairman)
Senior Director, Public Policy
sanofi-aventis
Bridgewater, New Jersey
Lyle Bootman, Ph.D.
Dean
College of Pharmacy
University of Arizona
Tucson, Arizona
Geoff Makinson, PhD
Director, Market Access
Pfizer Inc
New York, New York
C. Daniel Mullins, Ph.D.
Professor
Pharmaceutical Health Services
Research Department
University of Maryland School of Pharmacy
Baltimore, Maryland
Nancy C. Santanello, MD, MS
Vice President, Epidemiology
Merck Research Laboratories
North Wales, Pennsylvania
Sean D. Sullivan, Ph.D.
Professor and Director
Pharmaceutical Outcomes Research & Policy Program
Department of Pharmacy
University of Washington
Seattle, Washington

 

BENEFACTORS


The PHRMA Foundation owes its success to the pharmaceutical companies that have provided their generous support over the past 43 years.Use the arrows to scroll benefactors and click their logo to learn more about them.

View all benefactors.

 

Left direction
Right direction
logo

(C) 2010 PhRMA Foundation - 950 F Street, N.W. Suite 300 Washington, DC 20004